Delaying the Onset of Nearsightedness Until Treatment Study
Status:
Withdrawn
Trial end date:
2024-08-31
Target enrollment:
Participant gender:
Summary
Participants eligible for the study will be randomized to one of three concentrations of
atropine and followed for a month.
Phase:
Phase 1
Details
Lead Sponsor:
Ohio State University
Collaborators:
Case Western Reserve University Illinois College of Optometry Indiana University New England College of Optometry Pennsylvania College of Optometry Southern California College of Optometry at Marshall B. Ketchum University Southern College of Optometry Stanford University State University of New York University of California, Berkeley University of Houston University of Missouri, St. Louis University of the Incarnate Word